PRESS RELEASE published on 03/23/2026 at 11:44, 3 months 3 days ago Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology Research And Development Viromed Medical AG Scientific Innovation Cold Plasma Technology Funding Approval
BRIEF published on 03/19/2026 at 09:05, 3 months 7 days ago Viromed Medical AG nomme Anna Heinen au conseil de surveillance Stratégie D'entreprise Conseil De Surveillance Viromed Medical AG Technologie Du Plasma Froid Anna Heinen
BRIEF published on 03/19/2026 at 09:05, 3 months 7 days ago Viromed Medical AG Appoints Anna Heinen to Supervisory Board Supervisory Board Corporate Strategy Viromed Medical AG Cold Plasma Technology Anna Heinen
PRESS RELEASE published on 03/19/2026 at 09:00, 3 months 7 days ago Viromed Medical AG: Anna Heinen appointed to the Supervisory Board Anna Heinen appointed to the Supervisory Board of Viromed Medical AG, bringing expertise in corporate strategy and governance. She succeeds Frank Otto Governance Supervisory Board Corporate Strategy Viromed Medical AG Anna Heinen
BRIEF published on 03/04/2026 at 07:49, 3 months 22 days ago Viromed Medical AG entreprend l'acquisition de Relyon Plasma GmbH Acquisition Intégration Stratégique Viromed Medical AG Technologie Du Plasma Froid Relyon Plasma GmbH
BRIEF published on 03/04/2026 at 07:49, 3 months 22 days ago Viromed Medical AG Moves to Acquire Relyon Plasma GmbH Acquisition Strategic Integration Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
PRESS RELEASE published on 03/04/2026 at 07:44, 3 months 22 days ago Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, a key strategic step towards an integrated platform for cold plasma technology. The acquisition aims to strengthen Viromed's technological position and expand its market presence Acquisition Strategic Integration Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
BRIEF published on 03/03/2026 at 17:50, 3 months 23 days ago Viromed Medical AG va acquérir Relieon Plasma GmbH Dispositifs Médicaux Fusions Et Acquisitions Viromed Medical AG Technologie Du Plasma Froid Relion Plasma GmbH
BRIEF published on 03/03/2026 at 17:50, 3 months 23 days ago Viromed Medical AG to Acquire relyon plasma GmbH Medical Devices Mergers And Acquisitions Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
PRESS RELEASE published on 03/03/2026 at 17:45, 3 months 23 days ago EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, expanding its value chain and gaining expertise in atmospheric plasma technology Acquisition Letter Of Intent Plasma Technology Viromed Medical AG Relyon Plasma GmbH
Published on 06/26/2026 at 14:05, 5 hours 22 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 5 hours 27 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 6 hours 27 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 6 hours 42 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 19:10, 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/26/2026 at 18:04, 1 hour 23 minutes ago Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 1 hour 27 minutes ago PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 1 hour 27 minutes ago VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
Published on 06/26/2026 at 18:00, 1 hour 27 minutes ago VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 10,2 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de produits de santé naturels